Ensaio clínico

Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus (NO FEAR-BE)

NCT: NCT03554356 · ACTIVE_NOT_RECRUITING

ID NCTNCT03554356

EstadoACTIVE_NOT_RECRUITING

Data de início2018-09-04

SponsorUniversity of North Carolina, Chapel Hill (OTHER)

First posted2018-06-13

Last updated2026-09-14

Resumo breve

A multicenter, prospective, single arm, non randomized clinical trial to evaluate the safety and efficacy of the C2 CryoBalloon Focal Ablation System (CbFAS) for the treatment of persistent dysplasia or intestinal metaplasia (IM) in the tubular esophagus after 3 or more radiofrequency ablations (RFA) for dysplastic BE, or \<50% eradication of Barrett's Esophagus (BE) after 2 RFA treatments.

Fonte oficial

Ver no ClinicalTrials.gov →

Dados provenientes da API do ClinicalTrials.gov. Para consultar o estado mais recente, veja o registo oficial.